Results 31 to 40 of about 4,009 (198)

CD138 expression in MM cell lines.

open access: yes, 2014
(A) Dot plots showing the percentage of CD138++ and CD138low cells in MM cell lines. (B) Top: summary of the expression of CD19, CD20, CD27, CD38, CD45 and CD56 in CD138++ and CD138low subpopulations in MM cell lines.
Patryk Krzeminski (541133)   +11 more
core   +1 more source

Endometrium in focus of the gynecologist’s attention: the role of hysteroscopy and immunohistochemistry in the diagnosis of chronic endometritis, the choice of treatment

open access: yesРепродуктивная эндокринология, 2017
The aim of the study was to evaluate the immunohistochemical marker CD138 for the diagnosis of chronic endometritis in women with infertility and to explore the impact and effectiveness of Epigalin® (indole-3-carbinol – 200 mg, epigallocatechin-3-gallate
І. Т. Кишакевич   +2 more
doaj   +1 more source

Authenticity of newly dedifferentiated RPMI 8226 CD138- cells.

open access: yes, 2018
A) Sorted CD138+CD38+ populations were plated for four weeks, and then re-sorted based on CD138 status, to yield newly differentiated CD138+* and dedifferentiated CD138-* populations. Representative of N = 3.
Danielle Joseph (5920667)   +2 more
core   +1 more source

Plasmacytoid subtype of urothelial carcinoma – Report of two rare cases and unusual features

open access: yesIndian Journal of Pathology and Microbiology
Plasmacytoid urothelial carcinoma is a rare but aggressive subtype of urothelial carcinoma. The histopathologic mimics include plasmacytoma, metastasis from invasive lobular breast carcinoma, and gastric signet ring cell carcinoma.
Sagar Ranjan Tripathy   +3 more
doaj   +1 more source

Nuclear and mitochondrial genome instability induced by fractions of ethanolic extract from Hovenia dulcis Thunberg in Saccharomyces cerevisiae strains

open access: yesAnais da Academia Brasileira de Ciências, 2021
Hovenia dulcis is a plant commonly used as a pharmaceutical supplement, having displayed important pharmacological properties such antigiardic, antineoplastic and hepatoprotective.
LUANA B.N. DE ARAÚJO   +9 more
doaj   +1 more source

CD138++ cells give rise to CD138low cells and vice versa.

open access: yes, 2014
(A) The graphs represent the percentage of CD38++CD138++ and CD38++CD138low/- cells of primary and secondary CD138++ RPMI-8226 and CD138low RPMI-8226 derived tumors. Results are expressed as the means ± SEM (n = 4-6).
Patryk Krzeminski (541133)   +11 more
core   +1 more source

CD138− Plasmablastic Lymphoma: A Multi-institutional Study and Review of the Literature

open access: yesArchives of Pathology & Laboratory Medicine, 2022
Context.— Plasmablastic lymphoma (PBL) is a rare aggressive lymphoma, usually positive for CD138 and frequently occurring in the oral cavity of human immunodeficiency virus (HIV) patients. Up to 10% of cases are negative for CD138 and diagnostically very challenging.
Jui, Choudhuri   +12 more
openaire   +2 more sources

Sustained Delivery of a Shingles Subunit Vaccine Overcomes Age‐Related Declines in Humoral and Cellular Immunity Relative to Shingrix

open access: yesAdvanced Science, EarlyView.
Sustained delivery of a shingles subunit vaccine from an injectable polymer–nanoparticle hydrogel enhanced the potency, durability, and breadth of immune responses in aged mice while minimizing inflammatory cytokine production and reactogenicity. This strategy decouples immunogenicity from reactogenicity and offers a promising approach to improve ...
Ye Eun Song   +5 more
wiley   +1 more source

The monoclonal antibody nBT062 conjugated to maytansinoids has potent and selective cytotoxicity against CD138 positive multiple myeloma cells _in vitro_ and _in vivo_ [PDF]

open access: yes, 2008
CD138 (Syndecan1) is highly expressed on multiple myeloma (MM) cells. In this study, we examined the anti-MM effect of murine/human chimeric CD138-specific monoclonal antibody (mAb) nBT062 conjugated with highly cytotoxic maytansinoid derivatives _in ...
Christoph Uherek   +20 more
core  

SOX5 Orchestrates Malignant Evolution via Promoter‐Centric Chromatin Remodeling in MYC‐Driven B‐Cell Lymphoma

open access: yesAdvanced Science, EarlyView.
In MYC‐enforced B‐cell lymphoma, SOX5 occupies promoter‐proximal regulatory regions and is associated with reduced chromatin accessibility at the PCNP locus. PCNP repression promotes proliferative remodeling by limiting apoptosis and cell‐cycle restraint.
Yiyou Mao   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy